Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N G Shah

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1994
Can plasma prolactin predict tamoxifen resistance in patients with advanced breast cancer?J M Bhatavdekar, D D Patel, N H Karelia, et al.
Annals of Surgical Oncology|October 1, 1998
Overexpression of CD44: a useful independent predictor of prognosis in patients with colorectal carcinomasJ M Bhatavdekar, D D Patel, P R Chikhlikar, et al.
Cancer|February 1, 1994
Plasma prolactin in patients with colorectal cancer. Value in follow-up and as a prognosticatorD D Patel, J M Bhatavdekar, N Ghosh, et al.
Neoplasma|January 1, 1992
Endocrine status in stage II vs. advanced premenopausal and postmenopausal breast cancer patientsJ M Bhatavdekar, D D Patel, N G Shah, et al.
Neoplasma|January 1, 1992
Endocrine function in premenopausal and postmenopausal advanced breast cancer patients treated with CMF or tamoxifenJ M Bhatavdekar, N G Shah, D D Patel, et al.
British Journal of Cancer|November 1, 1992
Comparison of plasma prolactin and CEA in monitoring patients with adenocarcinoma of colon and rectumJ M Bhatavdekar, D D Patel, D D Giri, et al.
Diseases of the Colon and Rectum|July 1, 1997
Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinomaJ M Bhatavdekar, D D Patel, N Ghosh, et al.
The International Journal of Biological Markers|October 3, 2006
Stat3 expression in oral squamous cell carcinoma: association with clinicopathological parameters and survivalN G Shah, T I Trivedi, R A Tankshali, et al.
Cancer|May 1, 1990
Plasma prolactin as an indicator of disease progression in advanced breast cancerJ M Bhatavdekar, N G Shah, D B Balar, et al.
Neoplasma|January 1, 1994
Levels of circulating peptide and steroid hormones in men with lung cancerJ M Bhatavdekar, D D Patel, P R Chikhlikar, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1994
Can plasma prolactin predict tamoxifen resistance in patients with advanced breast cancer?J M Bhatavdekar, D D Patel, N H Karelia, et al.
Annals of Surgical Oncology|October 1, 1998
Overexpression of CD44: a useful independent predictor of prognosis in patients with colorectal carcinomasJ M Bhatavdekar, D D Patel, P R Chikhlikar, et al.
Cancer|February 1, 1994
Plasma prolactin in patients with colorectal cancer. Value in follow-up and as a prognosticatorD D Patel, J M Bhatavdekar, N Ghosh, et al.
Neoplasma|January 1, 1992
Endocrine status in stage II vs. advanced premenopausal and postmenopausal breast cancer patientsJ M Bhatavdekar, D D Patel, N G Shah, et al.
Neoplasma|January 1, 1992
Endocrine function in premenopausal and postmenopausal advanced breast cancer patients treated with CMF or tamoxifenJ M Bhatavdekar, N G Shah, D D Patel, et al.
British Journal of Cancer|November 1, 1992
Comparison of plasma prolactin and CEA in monitoring patients with adenocarcinoma of colon and rectumJ M Bhatavdekar, D D Patel, D D Giri, et al.
Diseases of the Colon and Rectum|July 1, 1997
Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinomaJ M Bhatavdekar, D D Patel, N Ghosh, et al.
The International Journal of Biological Markers|October 3, 2006
Stat3 expression in oral squamous cell carcinoma: association with clinicopathological parameters and survivalN G Shah, T I Trivedi, R A Tankshali, et al.
Cancer|May 1, 1990
Plasma prolactin as an indicator of disease progression in advanced breast cancerJ M Bhatavdekar, N G Shah, D B Balar, et al.
Neoplasma|January 1, 1994
Levels of circulating peptide and steroid hormones in men with lung cancerJ M Bhatavdekar, D D Patel, P R Chikhlikar, et al.
Pageof 5